$ARWR
ARROWHEAD PHARMACEUTICALS, INC. Stock $arwr

2012 Q1 Form 10-Q Financial Statement

Concept	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.700M
YoY Change	-47.14%
Cash & Equivalents	$3.595M
Short-Term Investments	$100.0K
Other Short-Term Assets	$500.0K
YoY Change	66.67%
Inventory
Prepaid Expenses
Receivables	$0.00
Other Receivables	$4.700M
Total Short-Term Assets	$8.800M
YoY Change	2.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.700M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.800M
YoY Change	-30.77%
Other Assets	$0.00
YoY Change
Total Long-Term Assets	$11.30M
YoY Change	71.21%
TOTAL ASSETS
Total Short-Term Assets	$8.800M
Total Long-Term Assets	$11.30M
Total Assets	$20.10M
YoY Change	32.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$800.0K
YoY Change	300.0%
Accrued Expenses	$3.500M
YoY Change	483.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$200.0K
YoY Change
Total Short-Term Liabilities	$6.400M
YoY Change	156.0%
LONG-TERM LIABILITIES
Long-Term Debt	$2.100M
YoY Change	320.0%
Other Long-Term Liabilities	$0.00
YoY Change
Total Long-Term Liabilities	$2.100M
YoY Change	320.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.400M
Total Long-Term Liabilities	$2.100M
Total Liabilities	$7.800M
YoY Change	143.75%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.20M
YoY Change
Total Liabilities & Shareholders Equity	$20.10M
YoY Change	32.24%

Concept	2012 Q1
OPERATING ACTIVITIES
Net Income	-$5.335M
YoY Change	-283.34%
Depreciation, Depletion And Amortization	$423.9K
YoY Change
Cash From Operating Activities	-$4.200M
YoY Change	223.08%
INVESTING ACTIVITIES
Capital Expenditures	-$200.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$200.0K
YoY Change	-81.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.200M
YoY Change	-33.33%
NET CHANGE
Cash From Operating Activities	-4.200M
Cash From Investing Activities	-200.0K
Cash From Financing Activities	1.200M
Net Change In Cash	-3.200M
YoY Change	433.33%
FREE CASH FLOW
Cash From Operating Activities	-$4.200M
Capital Expenditures	-$200.0K
Free Cash Flow	-$4.000M
YoY Change	207.69%

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10663869